Canadian Medical Marijuana & Cannabis Industry News

Licensed outdoor cannabis canopy exceeds indoor for first time in Canada

The amount of space licensed to grow cannabis in Canada is now heavily skewed toward outdoor cultivation instead of indoor for the first time, according to new data from Health Canada. The federal regulator said it has licensed roughly 13 million square feet of indoor cannabis cultivation (including greenhouse), versus 19 million square feet approved […]

Read More

Executive exodus continues in cannabis boardrooms with Sundial CEO’s resignation

Turnover inside the boardrooms of Canadian cannabis producers shows no sign of slowing. Cannabis producer Sundial Growers said Thursday that Torsten Kuenzlen stepped down as a director and CEO “to pursue other interests.” His departure is effective immediately. Kuenzlen joined the Calgary, Alberta-based company to much fanfare – and high expectations – in 2018. However, Sundial’s stock has […]

Read More

Medical cannabis flower imported into Germany doubles again in 2019, confirming strong growth

Germany imported 6,714 kilograms (14,802 pounds) of medical cannabis flower, primarily for pharmacy dispensing in 2019, according to fresh data from the nation’s medical regulatory agency. That’s more than double the total for 2018, when about 3 metric tons were imported. Data from the Federal Institute for Drugs and Medical Devices (BfArM) confirms the strong […]

Read More

Australia says over-the-counter CBD sales ‘could be considered during 2020’

A review of cannabidiol products being undertaken by Australian health authorities could result in the relaxation of the scheduling status of CBD, potentially making it available over the counter in low doses. In a public submission to a Senate committee studying Australia’s medical cannabis access scheme, the Department of Health said the Therapeutic Goods Administration […]

Read More

Aphria secures CA$100 million injection from anonymous investor

Canadian cannabis producer Aphria said Friday it has entered into an agreement with an institutional investor for a strategic investment worth 100 million Canadian dollars ($76 million). Chief Corporate Affairs Officer Tamara Macgregor told Marijuana Business Daily the investor requested to remain anonymous. The investor agreed to purchase just over 14 million Aphria units at CA$7.12 apiece. […]

Read More

Aurora Cannabis offshoot Australis Capital announces CFO departure

Australis Capital, an investment group that spun off from Canada’s Aurora Cannabis, announced the departure of Chief Financial Officer Michael Carlotti. In a brief news release issued after market close on Jan. 17, Las Vegas-based Australis said Carlotti’s employment had been “terminated” effective Jan. 16. The company gave no explanation for the move. Alex Han will […]

Read More

Aphria One, Brampton subsidiary receive EU-GMP certifications, clearing way for European cannabis exports

Aphria has received its first two essential European quality standard certifications, which the Canadian medical cannabis producer says will allow it to export finished dried flower and oil in bulk to European Union countries with established medical marijuana regimes. The company earned a certificate of EU-Good Manufacturing Practice (GMP) compliance on Jan. 15 for its […]

Read More